Bonk Inc. (BNKK) Next Earnings Date & Expected ±12.5% Move

$1.08 -8.47% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.06

Bonk Inc. (BNKK) carries a Roarable Rating of E (Strong Sell) with 32/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $8.6M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on BNKK Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is BNKK stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Bonk Inc. (NASDAQ: BNKK) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $1.08 (-8.47% 1D, market cap $8.6M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 5/20. Across 1011 tracked Consumer Discretionary issuers, BNKK ranks #856 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does BNKK compare to BYAH and CABR in the Consumer Discretionary sector?
▼

Within the Consumer Discretionary sector (Package Goods/Cosmetics), BNKK carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of 58.5%, and ROIC of -35.0%. By comparison, BYAH (Park Ha Biological Technology Co. Ltd. (Class A)) holds a D- grade (43/100 RQD, P/E N/A, ROIC —, cap $7.6M) and CABR (Caring Brands Inc.) posts a D- grade (40/100 RQD, P/E N/A, ROIC -35.0%, cap $11.8M). Among the 5-stock peer group, UG leads on earnings multiple (14.5x) while UG leads on capital efficiency (17.8% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for BNKK?
▼

Per BNKK's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001760903), Bonk Inc. generated $2.1M in revenue (+201.6% YoY), -$68.2M in net income, and -$25.3M in free cash flow against $41.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $1.06 (-1.71%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 7/20 (D-) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (32/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.2% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERRED ALERT • E
025507510032
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D-
Cash (7)Whales (3)SEC (11)Macro (6)CEO (5)
Each axis scored 0–20
12M PRICE TARGET CONE-12% Base Target
$9 Bull$1 Base$1 Bear
📬 FREE BNKK RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BNKK)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (32/100 Composite)
🔍 WHY BNKK SCORES 32/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+11/20 pts (34% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9

▲ #2 Bullish Driver: Cash Engine Quality+7/20 pts (22% of score)

SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 58.5% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
40
Grade D$1.29-9.3% Next Q
Q2 (-2Q)
37
Grade E$1.17-5.1% Next Q
Q3 (-1Q)
35
Grade E$1.11-2.7% Next Q
Current
32
Grade E$1.08-9.2% Hist 90D α
Trajectory: D (40) → E (32)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a BNKK Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While BNKK currently carries a cautious 32/100 (E) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Consumer Discretionary with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.36) and Max Pain ($1.13) forces dealer call-delta covering toward $9.33.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $BNKK• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “BNKK Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
NEXT EST. WINDOW: Dec 30, 2026 (~57 DAYS)

Historical OHLCV Volatility ±12.5% Swing Band

±$0.14 Expected Swing
$1.00 (-12.5%)Spot $1.08$1.22 (+12.5%)
MODEL EARNINGS SETUP GAUGE

BNKK Quantitative Pre-Earnings Setup: 32/100

Trailing EPS: $4.25 • YoY Revenue Growth: 180%

Model Bullish Setup (32/100)Model Risk Weight (68/100)
Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).
LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

PeriodFiledRevenueNet ProfitFree Cash FlowGross Margin
FY 20252025-12-31$2.1M-$68.2M-$25.3M58.5%
FY 20242024-12-31$702.0K-$49.4M-$18.2M-50%
FY 20232023-12-31$202.7K-$15.1M-$10.5M58.5%
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BNKK)

  • ✓Walkthrough of BNKK's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
BNKK // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -57.31%🛡️ HOLDING TREND SUPPORT
2026-11-03O $1.18H $1.18L $1.08C $1.08VOL 76.0K
RES: $2.43SUP: $0.90SMA50: $1.36SMA200: $2.11
$9.07$6.86$4.64$2.43$0.21RES $2.43SUP $0.90$1.082026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BNKK Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth

vs. +180.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BNKK today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BNKK. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for BNKK today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BNKK)

Consumer Discretionary Rank #856 of 1011 ⚔️ BYAH vs BNKK Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (BNKK vs. BYAH, CABR, YCBD, UG)

Industry: Package Goods/Cosmetics (23 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Bonk Inc. (BNKK) ranks #856 by composite RQD confidence (32/100, grade E) and #937 by equity capitalization ($8.6M). Within this direct 5-issuer industry benchmark cohort, UG leads on earnings valuation at 14.5x trailing P/E, while UG leads on capital efficiency and profitability with 17.8% ROIC and — gross margin. UG currently holds the highest overall quantitative score in the immediate peer group at 71/100 (B-) compared with BNKK at 32/100 (E).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
BNKK ACTIVE
Bonk Inc.
E 32/100 — 58.5% -35.0% -8.47% $8.6M Benchmark Subject
BYAH
Park Ha Biological Technology Co. Ltd. (Class A)
D- 43/100 — 94.4% — -3.91% $7.6M /byah-vs-bnkk →
CABR
Caring Brands Inc.
D- 40/100 — 55.6% -35.0% +5.61% $11.8M /cabr-vs-bnkk →
YCBD
cbdMD Inc.
D- 36/100 — 62.4% -30.4% -1.34% $4.3M /ycbd-vs-bnkk →
UG
United-Guardian Inc.
B- 71/100 14.5x — 17.8% +6.16% $32.5M /ug-vs-bnkk →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001760903

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Bonk Inc. (BNKK) reported GAAP revenue of $2.1M (+201.6% vs. FY2024 revenue of $702.0K , and +944.7% cumulative change since FY2023) , GAAP net income of -$68.2M, operating cash flow of -$25.3M, and free cash flow of -$25.3M (-39.1% YoY). On the balance sheet, BNKK closed FY2025 with $41.0M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $2.1M -$68.2M -$25.3M -$25.3M $41.0M —
FY2024 (FY) 2024-12-31 $702.0K -$49.4M -$18.1M -$18.2M $7.3M —
FY2023 (FY) 2023-12-31 $202.7K -$15.1M -$10.5M -$10.5M — —

3. BNKK Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BNKK stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Bonk Inc. (NASDAQ: BNKK) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $1.08 (-8.47% 1D, market cap $8.6M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 5/20. Across 1011 tracked Consumer Discretionary issuers, BNKK ranks #856 in composite RQD confidence.

How does BNKK compare to BYAH and CABR in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Package Goods/Cosmetics), BNKK carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of 58.5%, and ROIC of -35.0%. By comparison, BYAH (Park Ha Biological Technology Co. Ltd. (Class A)) holds a D- grade (43/100 RQD, P/E N/A, ROIC —, cap $7.6M) and CABR (Caring Brands Inc.) posts a D- grade (40/100 RQD, P/E N/A, ROIC -35.0%, cap $11.8M). Among the 5-stock peer group, UG leads on earnings multiple (14.5x) while UG leads on capital efficiency (17.8% ROIC).

What are the biggest fundamental strengths and SEC risk factors for BNKK?

Per BNKK's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001760903), Bonk Inc. generated $2.1M in revenue (+201.6% YoY), -$68.2M in net income, and -$25.3M in free cash flow against $41.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is BNKK trading relative to its 50-day, 200-day, and 52-week technical levels?

BNKK last traded at $1.08 (-8.47% on volume of 76,019 shares), positioning the stock -20.59% below its 50-day simple moving average ($1.36) and -48.82% below its 200-day simple moving average ($2.11). Across its 52-week range of $0.90 to $8.89, BNKK sits at the 2.3% percentile with a 14-day RSI of 40.7 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.00 to $1.22).

BNKK Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

When is BNKK's next earnings date?

Based on SEC filing cadence, Bonk Inc. (BNKK)'s next quarterly reporting window is estimated around Dec 30, 2026.

How much is BNKK stock expected to move on earnings?

Volatility modeling currently projects a ±12.5% event move for BNKK, spanning a range between $1 and $1.22.

ROARABLE RATING BRIEF • RQD 32/100 (E) ✓ STAGE-C NUMBER FIREWALL VERIFIED

BNKK — Bonk Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:51:58Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, BNKK scores 35 out of 100 with a letter grade of D-, labeled "Roarable Sell — Vulnerable Balance Sheet & Flow."

  • Fundamental Cash Engine (7 / 20): Per the Roarable RQD rating, this pillar reflects ROIC of -35% and an FCF yield of 0%. For a prospective investor, the core earnings engine is not currently generating returns on capital or free cash flow to shareholders, so any valuation case must rest on future operating change rather than present cash generation.
  • Whale 13F Flow (5 / 20): Per the Roarable RQD rating, this pillar covers institutional accumulation and options positioning. The low score indicates weak institutional support in the source data, which tends to reduce the buyer base that could absorb selling pressure.
  • Insider Conviction (5 / 20): Per the Roarable RQD rating, this pillar reflects SEC Form 4 and Congressional PTR cluster flow. The low score signals limited evidence of insider conviction supporting the stock.
  • Macro Regime Fit (7 / 20): Per the Roarable RQD rating, beta is 1.0 with sector sensitivity noted. A beta of 1.0 means the stock is expected to move roughly in line with the market, so it offers no defensive cushion; the pillar score reflects sector-level sensitivity rather than a strong macro tailwind.
  • Forensic Balance Sheet (11 / 20): Per the Roarable RQD rating, the Altman Z-Score is 2.5, Piotroski F-Score is 4/9, and Debt/Equity is 0.5. This is the strongest pillar, but it remains only moderate, indicating balance sheet vulnerability rather than a clean bill of health.

Taken together, the sub-scores suggest that the main drag is the absence of cash generation and weak market-flow support, not balance sheet collapse alone. Valuation tradeoffs are significant: with a market capitalization of $9.4M and an operating margin of 0%, the stock's value is highly sensitive to whether revenue growth can convert into operating profit. Upside would require visible margin improvement and sustained institutional or insider interest; downside risk is elevated given the negative net margin and the 52-week range of $0.9 - $8.89, which shows substantial price volatility.

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025$2.1M$0.0M$-68.2MN/A$-25.3MN/AN/A
FY 2024$0.7M$0.0M$-49.4MN/A$-18.2MN/AN/A
FY 2023$0.2M$0.0M$-15.1MN/A$-10.5MN/AN/A

Reported revenue rose from $0.2M in FY 2023 to $2.1M in FY 2025 while net losses widened from $-15.1M to $-68.2M. Per the market data, gross margin is 58.5%, operating margin is 0%, and net margin is -60%, with ROIC of -35%. Per the Roarable RQD rating, the Altman Z-Score is 2.5 and the Piotroski F-Score is 4/9. Cash and debt balances by period are Not available in source data beyond the Debt/Equity ratio of 0.5 cited in the RQD rating.

Open Questions

  • What are the cash, debt, and EPS values for each reported period, given that these fields are marked N/A in the financials?
  • What products and customer segments generate the reported revenue, and what drove the increase from $0.2M to $2.1M?
  • What is the path to positive operating income, given operating margin of 0% alongside net losses of $-68.2M in FY 2025?
  • Who are the institutional and insider holders, and what is their recent activity?
  • What is the company's cash runway given FCF of $-25.3M in FY 2025 and no reported cash balance?

BNKK Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Bonk Inc. (BNKK) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to BNKK Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

BNKK Bull vs. Bear Conversation Board — What's Your Call at $1.08?

🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON BNKK 🐻 67% BEARISH CONVICTION
1. Pick Your Side on BNKK:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH 🎯 Target: $1.04 (-11.9%)
📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is BNKK (D- • RQD 35/100) a Buy at $1.18?

Welcome to the BNKK (Bonk Inc.) Roar Pit. Current RQD Composite is 35/100 (Roarable Sell — Vulnerable Balance Sheet & Flow) in Package Goods/Cosmetics. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

FO ForensicBear Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $0.93 (-21.2%)
Spot @ $1.18

Pump the brakes on BNKK — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on BNKK, but look at what you are paying: current EV/EBITDA multiples with 58.5% gross margins. Unless Bonk Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

MI MidwestValue Verified K Arena Trader 🐂 BULLISH 🎯 Target: $1.40 (+18.6%)
Spot @ $1.18

BNKK cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on BNKK, the market is fixating on short-term headline noise in Package Goods/Cosmetics and ignoring the balance sheet and cash flow trajectory. At $1.18 (52-wk range $0.90 - $8.89), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.35 -5.42% GLD $361.65 -3.59%